Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora Doretta Mistras as Chief Financial Officer, Effective March 1, 2024, and Philippe Martin as Chief R&D Officer

Company thanks Sanjeev Narula for his role in the successful execution of Viatris' Phase 1 strategy; Narula will support a smooth CFO transition prior to his departure on March 1, 2024
PITTSBURGH,...

Related Keywords

Shanghai ,China ,India ,Hyderabad ,Andhra Pradesh ,Sanjeev Narula ,Theodora Doretta Mistras ,Scotta Smith ,Centocor Johnson ,Philippe Martin ,Goldman Sachs ,Doretta Mistras ,Exchange Commission ,Viatris Inc ,Nasdaq ,Schering ,Prnewswire Viatris Inc ,Philippe ,Linkedin ,Youtube ,Twitter ,Instagram ,Regulatory Affairs ,Viatri Phase ,Chief Financial Officer ,Chief Rd Officer ,Managing Director ,Healthcare Investment Banking ,Citigroup Global Markets ,Chief Executive Officer ,Private Securities Litigation Reform Act ,Fair Disclosure ,Markets ,